Author

M. Subklewe

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Research Focus:cell-cell communication· 1 Assay:flow cytometry· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

M. von Bergwelt-Baildon· 2 shared A. Altendorf-Hofmann· 1 shared A. B. Krug· 1 shared A. Leutbecher· 1 shared A. Reischer· 1 shared C. D. Strobl· 1 shared C. Ludwig· 1 shared C. Scherer· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

M. von Bergwelt-Baildon

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ARID1A Mutations Protect Follicular Lymphoma from FAS-dependent Immune Surveillance by Reducing RUNX3/ETS1-Driven FAS-Expression

M. Antoniolli, M. Solovey, C. D. Strobl, D. Bararia, W. D. Keay, J. A. Hildebrand, L. Adolph, M. Heide, V. Passerini, T. Freyholdt, L. Wange, W. Enard, S. Thieme, H. Blum, M. Rudelius, , O. Weigert

This study identifies ARID1A mutations in follicular lymphoma that reduce FAS expression, enabling immune evasion by disrupting RUNX3/ETS1 regulation.

bioRxiv · Dec 12, 2023 · PreprintCancer Biology

Impaired function and delayed regeneration of dendritic cells in COVID-19

E. Winheim, L. Rinke, K. Lutz, A. Reischer, A. Leutbecher, L. Wolfram, L. Rausch, J. Kranich, P. R. Wratil, J. Huber, D. Baumjohann, S. Rothenfusser, J. Hellmuth, C. Scherer, M. Muenchhoff, , A. B. Krug

This study examines dendritic cell and monocyte function and regeneration in COVID-19 patients, finding persistent reductions and functional impairments linked to disease severity.

bioRxiv · May 26, 2021 · PreprintImmunology

Expression patterns of PD-L1 and PD-1 provide rationales for immune checkpoint inhibition in soft tissue sarcomas

M. F. Orth, V. L. Buecklein, E. Kampmann, M. Subklewe, E. Noessner, F. Cidre-Aranaz, L. Romero-Perez, F. S. Wehweck, L. Lindner, R. Issels, T. Kirchner, A. Altendorf-Hofmann, T. G. P. Grunewald, T. Knoesel

This study examines PD-L1 and PD-1 expression in soft tissue sarcomas and finds associations with TILs and poor clinical outcomes, supporting immune checkpoint inhibition in PD-L1-positive cases.

bioRxiv · Mar 8, 2019 · PreprintCancer Biology